Silence Therapeutics (SLN) Enterprise Value: 2019-2025
Historic Enterprise Value for Silence Therapeutics (SLN) over the last 7 years, with Sep 2025 value amounting to -$122.4 million.
- Silence Therapeutics' Enterprise Value fell 52.01% to -$122.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$122.4 million, marking a year-over-year decrease of 52.01%. This contributed to the annual value of -$147.3 million for FY2024, which is 39.31% down from last year.
- As of Q3 2025, Silence Therapeutics' Enterprise Value stood at -$122.4 million, which was up 34.43% from -$186.6 million recorded in Q2 2025.
- Silence Therapeutics' Enterprise Value's 5-year high stood at -$37.2 million during Q2 2023, with a 5-year trough of -$208.1 million in Q1 2025.
- Its 3-year average for Enterprise Value is -$118.3 million, with a median of -$122.4 million in 2025.
- Per our database at Business Quant, Silence Therapeutics' Enterprise Value plummeted by 693.15% in 2021 and then soared by 42.73% in 2023.
- Over the past 5 years, Silence Therapeutics' Enterprise Value (MRQ) stood at -$99.1 million in 2021, then skyrocketed by 35.14% to -$64.3 million in 2022, then crashed by 64.49% to -$105.8 million in 2023, then crashed by 39.31% to -$147.3 million in 2024, then increased by 16.95% to -$122.4 million in 2025.
- Its Enterprise Value stands at -$122.4 million for Q3 2025, versus -$186.6 million for Q2 2025 and -$208.1 million for Q1 2025.